Inventor · disambiguated record
Nathan Oliver Fuller
Also filed as: FULLER NATHAN OLIVER
11 granted patents·13 pending applications·45 citations·filing 2011–2025
89Inventor score
Files withALKERMES INC10BRONK BRIAN SCOTT7RODIN THERAPEUTICS INC5RECTIFY PHARMACEUTICALS INC1SATORI PHARMACEUTICALS INC1
Top patents by PatentIndex Score
24 records- 0197US9951069B1Bicyclic inhibitors of histone deacetylaseRODIN THERAPEUTICS INC·Filed 2018·Granted Apr 24, 2018·13 cites·2 claims
- 0296US11225479B2Bicyclic inhibitors of histone deacetylaseALKERMES INC·Filed 2020·Granted Jan 18, 2022·3 cites·5 claims
- 0394US10793567B2Bicyclic inhibitors of histone deacetylaseRODIN THERAPEUTICS INC·Filed 2018·Granted Oct 6, 2020·7 cites·16 claims
- 0494US10696673B2Bicyclic inhibitors of histone deacetylaseRODIN THERAPEUTICS INC·Filed 2019·Granted Jun 30, 2020·5 cites·3 claims
- 0593US10919902B2Hetero-halo inhibitors of histone deacetylaseALKERMES INC·Filed 2019·Granted Feb 16, 2021·4 cites·1 claims
- 0692US11286256B2Bicyclic inhibitors of histone deacetylaseALKERMES INC·Filed 2020·Granted Mar 29, 2022·2 cites·2 claims
- 0792US10519149B2Bicyclic inhibitors of histone deacetylaseRODIN THERAPEUTICS INC·Filed 2018·Granted Dec 31, 2019·8 cites·3 claims
- 0888US11225475B2Substituted pyridines as inhibitors of histone deacetylaseALKERMES INC·Filed 2018·Granted Jan 18, 2022·3 cites·16 claims
- 0979US11987580B2Bicyclic inhibitors of histone deacetylaseALKERMES INC·Filed 2021·Granted May 21, 2024·0 cites·17 claims
- 1073US11858939B2Hetero-halo inhibitors of histone deacetylaseALKERMES INC·Filed 2020·Granted Jan 2, 2024·0 cites·1 claims
- 1172US11912702B2Substituted pyridines as inhibitors of histone deacetylaseALKERMES INC·Filed 2021·Granted Feb 27, 2024·0 cites·10 claims
- 1251US2022267323A1Synthesis of bicyclic inhibitors of histone deacetylaseALKERMES INC·Filed 2020·Application pending·0 cites
- 1350US2018194769A1Hetero-halo inhibitors of histone deacetylaseRODIN THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 1447US2025228835A1Pyridinyloxypyridines and related compounds and their use in treating medical conditionsRECTIFY PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 1546US2021276978A1Inhibitors of histone deacetylaseALKERMES INC·Filed 2019·Application pending·0 cites
- 1646US2021276977A1Bicyclic inhibitors of histone deacetylaseALKERMES INC·Filed 2019·Application pending·0 cites
- 1740US2013060022A1Compounds useful for treating neurodegenerative disordersBRONK BRIAN SCOTT·Filed 2012·Application pending·0 cites
- 1840US2013060023A1Compounds useful for treating neurodegenerative disordersBRONK BRIAN SCOTT·Filed 2012·Application pending·0 cites
- 1940US2013060021A1Compounds useful for treating neurodegenerative disordersBRONK BRIAN SCOTT·Filed 2012·Application pending·0 cites
- 2040US2013060019A1Compounds for Use in Treating Neurodegenerative Disorders, Synthesis Thereof, and Intermediates TheretoBRONK BRIAN SCOTT·Filed 2012·Application pending·0 cites
- 2140US2013060024A1Compounds useful for treating neurodegenerative disordersBRONK BRIAN SCOTT·Filed 2012·Application pending·0 cites
- 2237US2013060013A1Compounds useful for treating neurodegenerative disordersBRONK BRIAN SCOTT·Filed 2012·Application pending·0 cites
- 2335US2013060020A1Compounds useful for treating neurodegenerative disordersBRONK BRIAN SCOTT·Filed 2012·Application pending·0 cites
- 2430US2011251379A1Compounds useful for treating neurodegenerative disordersSATORI PHARMACEUTICALS INC·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Nathan Oliver Fuller files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →